Outsourced Pharma App Notes & Case Studies

1. Analytical Procedure Development Following ICH Q14 7/23/2025

   Review how the new ICH Q14 guidance and AQbD principles can transform analytical method development into a more efficient, robust, and regulatory-ready process.

2. Advancing Your API To First Human Dose Trials More Efficiently 2/7/2024

   Learn how end-to-end support for development and manufacturing, clinical trial services, advanced drug delivery, and commercial packaging can accelerate drug development and time to market.

3. Impact Of Glycosylation On The Effector Functions Of Monoclonal Antibodies 2/9/2024

   In an example using rituximab and its biosimilars, explore the significance of minor differences of glycosylation in antibodies and its impact on their properties and functionality.

4. Product Manufacturing And Analytical Testing For An Ocular Client 1/8/2024

   Unearth how Altascienes manages procurement logistics, manufactures the product, performs analytical testing, and terminally sterilizes it for final delivery.

5. Bend Successfully Rescues Powder-Filled Capsule Program 5/16/2025

   Learn how to overcome tech transfer challenges and ensure consistent content uniformity by leveraging multidisciplinary expertise and decades of commercial encapsulation experience.

6. In Vivo RNA Tuning for Liver Gene Editing Efficiency 10/28/2025

   RNA sequence and guide modifications, delivery platform design, and dose optimization all contribute to improved gene editing outcomes, which offers a clearer path toward safer, more potent, and scalable mRNA-based therapeutics.

7. Advancements In GLP-1 Analog Formulation: Overcoming Challenges 2/3/2025

   Oral GLP-1 formulations represent a groundbreaking advance in obesity treatment to offer improved patient comfort and adherence while expanding the therapeutic market.

8. Review Of Applications And Processes In Fixed-Bed Bioreactors 5/6/2024

   Gain insights and guidelines for developing new processes in this review evaluating publications on the applications of single-use, scalable fixed-bed bioreactors for adherent cell culture processes.

9. Lentiviral Vector Production Using Single-Use Bioreactors 5/6/2024

   Here, we outline a scalable and robust upstream process developed for LVV production of HEK293T cells and demonstrate how to expand HEK293T suspension cells.

10. A Comparative Efficiency Analysis Of Commercial Transfection Reagents In HEK 293 Cells 3/27/2025

    This study presents a detailed comparative analysis of the efficiency, viability, and cytotoxic effects of four widely used transfection reagents on Human Embryonic Kidney 293 (HEK293) cells.